Malaria drug Chloroquine helps fight treatment resistant brain cancer

After her brain cancer became resistant to chemotherapy and then to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months to live. Now a paper published in the journal eLife describes a new drug combination that has stabilized Rosendahl’s disease and increased both the quantity and quality of her life: Adding the … Continue reading Malaria drug Chloroquine helps fight treatment resistant brain cancer

Artificial intelligence project to identify skin cancer based on machine learning algorithm works as good as a doctor

Universal access to health care was on the minds of computer scientists at Stanford when they set out to create an artificially intelligent diagnosis algorithm for skin cancer. They made a database of nearly 130,000 skin disease images and trained their algorithm to visually diagnose potential cancer. From the very first test, it performed with … Continue reading Artificial intelligence project to identify skin cancer based on machine learning algorithm works as good as a doctor

New Imaging technique to detect Chromatin in the cell (Partial Wave Spectroscopic Microscopy)

When scientists finished decoding the human genome in 2003, they thought the findings would help us better understand diseases, discover genetic mutations linked to cancer, and lead to the design of smarter medicine. Now it’s 13 years later, and not all of these ideas have not yet come to fruition. It turns out that genes … Continue reading New Imaging technique to detect Chromatin in the cell (Partial Wave Spectroscopic Microscopy)

New targeted epigenetic therapy for lymphoma shows promise

New compounds targeting epigenetics have shown promise in treating patients with lymphoma, according to data presented at the Targeted Anticancer Therapies International Congress 2018 in Paris, France. ESMO’s phase-I oncology meeting featured early clinical studies with BET inhibitors and EZH2 inhibitors. Dr. Anastasios Stathis, head of the New Drugs Development Unit of the Oncology Institute … Continue reading New targeted epigenetic therapy for lymphoma shows promise

Scientists develop nanoscale sensor to detect heart attack

An international collaboration of scientists involving a team of researchers at Manchester led by Dr David J. Lewis has developed a tiny electric sensor, which could potentially improve patient survival rates by telling doctors if a person has had a heart attack. Cardiovascular diseases account for around 30% of adult deaths in the 30−70 year … Continue reading Scientists develop nanoscale sensor to detect heart attack